{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:05:26Z","timestamp":1790823926846,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,9,27]],"date-time":"2011-09-27T00:00:00Z","timestamp":1317081600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s00125-011-2310-6","type":"journal-article","created":{"date-parts":[[2011,9,26]],"date-time":"2011-09-26T12:04:02Z","timestamp":1317038642000},"page":"3028-3036","source":"Crossref","is-referenced-by-count":136,"title":["Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS)"],"prefix":"10.1007","volume":"54","author":[{"given":"N.","family":"Furusyo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Otokozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Kohzuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Ikezaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. J.","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,27]]},"reference":[{"key":"2310_CR1","first-page":"573","volume":"40","author":"SM Genuth","year":"1995","unstructured":"Genuth SM (1995) The case for blood glucose control. Adv Intern Med 40:573\u2013623","journal-title":"Adv Intern Med"},{"key":"2310_CR2","doi-asserted-by":"crossref","first-page":"968","DOI":"10.2337\/diabetes.44.8.968","volume":"44","author":"The Diabetes Control and Complications Trial Research Group","year":"1995","unstructured":"The Diabetes Control and Complications Trial Research Group (1995) The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 44:968\u2013983","journal-title":"Diabetes"},{"key":"2310_CR3","doi-asserted-by":"crossref","unstructured":"DECODE Study Group (1999) Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: collaborative analysis of diagnostic criteria in Europe. Lancet 354:617\u2013621.","DOI":"10.1016\/S0140-6736(98)12131-1"},{"key":"2310_CR4","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2337\/diacare.22.6.920","volume":"22","author":"M Tominaga","year":"1999","unstructured":"Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A (1999) Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 22:920\u2013924","journal-title":"Diabetes Care"},{"key":"2310_CR5","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/jama.290.4.486","volume":"290","author":"JL Chiasson","year":"2003","unstructured":"Chiasson JL, Josse RG, Gomis R et al (2003) Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 290:486\u2013494","journal-title":"JAMA"},{"key":"2310_CR6","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837\u2013853","journal-title":"Lancet"},{"key":"2310_CR7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0168-8227(95)01064-K","volume":"28","author":"Y Ohkubo","year":"1995","unstructured":"Ohkubo Y, Kishikawa H, Araki E et al (1995) Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28:103\u2013117","journal-title":"Diabetes Res Clin Pract"},{"key":"2310_CR8","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.2337\/dc09-9033","volume":"32","author":"The International Expert Committee","year":"2009","unstructured":"The International Expert Committee (2009) International committee report on the role of the A1c assay in the diagnosis of diabetes. ADA Workgroup report. Diabetes Care 32:1328\u20131334","journal-title":"Diabetes Care"},{"key":"2310_CR9","unstructured":"WHO (2011) Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus: abbreviated report of a WHO consultation. www.who.int\/cardiovascular_diseases\/report-HbA1c_2011_edited.pdf . Accessed 20 January 2011"},{"key":"2310_CR10","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1073\/pnas.76.9.4258","volume":"76","author":"CE Guthrow","year":"1979","unstructured":"Guthrow CE, Morris MA, Day JF, Thorpe SR, Baynes JW (1979) Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus. Proc Natl Acad Sci USA 76:4258\u20134261","journal-title":"Proc Natl Acad Sci USA"},{"key":"2310_CR11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1507\/endocrj.K06-103","volume":"54","author":"S Takahashi","year":"2007","unstructured":"Takahashi S, Uchino H, Shimizu T et al (2007) Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control. Endocr J 54:139\u2013144","journal-title":"Endocr J"},{"key":"2310_CR12","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/clinchem\/47.4.756","volume":"47","author":"LY Tsai","year":"2001","unstructured":"Tsai LY, Tsai SM, Lin MN, Liu SF (2001) Effect of hemoglobin variants (Hb J, Hb G, and Hb E) on HbA1c values as measured by cation-exchange HPLC (Diamat). Clin Chem 47:756\u2013758","journal-title":"Clin Chem"},{"key":"2310_CR13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cca.2009.05.015","volume":"406","author":"M Ai","year":"2009","unstructured":"Ai M, Otokozawa S, Schaefer EJ et al (2009) Glycated albumin and direct low density lipoprotein cholesterol levels in type 2 diabetes mellitus. Clin Chim Acta 406:71\u201374","journal-title":"Clin Chim Acta"},{"key":"2310_CR14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0009-8981(02)00207-3","volume":"324","author":"T Kouzuma","year":"2002","unstructured":"Kouzuma T, Usami T, Yamakoshi M, Takahashi M, Imamura S (2002) An enzymatic method for the measurement of glycated albumin in biological samples. Clin Chim Acta 324:61\u201371","journal-title":"Clin Chim Acta"},{"key":"2310_CR15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1507\/endocrj.K07E-089","volume":"55","author":"K Yoshiuchi","year":"2008","unstructured":"Yoshiuchi K, Matsuhisa M, Katakami N et al (2008) Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes. Endocr J 55:503\u2013507","journal-title":"Endocr J"},{"key":"2310_CR16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1507\/endocrj.K09E-234","volume":"57","author":"T Suwa","year":"2010","unstructured":"Suwa T, Ohta A, Matsui T et al (2010) Relationship between clinical markers of glycemia and glucose excursion evaluated by continuous glucose monitoring (CGM). Endocr J 57:135\u2013140","journal-title":"Endocr J"},{"key":"2310_CR17","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.clinbiochem.2007.03.022","volume":"40","author":"L Lu","year":"2007","unstructured":"Lu L, Pu LJ, Xu XW et al (2007) Association of serum levels of glycated albumin, C-reactive protein and tumor necrosis factor-alpha with the severity of coronary artery disease and renal impairment in patients with type 2 diabetes mellitus. Clin Biochem 40:810\u2013816","journal-title":"Clin Biochem"},{"key":"2310_CR18","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5551\/jat.3731","volume":"30","author":"H Ohnishi","year":"2010","unstructured":"Ohnishi H, Sawayama Y, Furusyo N, Maeda S, Tokunaga S, Hayashi J (2010) Risk factors for and the prevalence of peripheral arterial disease and its relationship to carotid atherosclerosis: the Kyushu and Okinawa Population Study (KOPS). J Atheroscler Thromb 30:751\u2013758","journal-title":"J Atheroscler Thromb"},{"key":"2310_CR19","doi-asserted-by":"crossref","unstructured":"Koga M, Murai J, Saito H, Otsuki M, Kasayama S (2011) Evaluation of glycated albumin\/HbA1c ratio by stage of diabetic nephropathy. Diabetol Int. doi: 10.1007\/s13340-011-0033-z","DOI":"10.1007\/s13340-011-0033-z"},{"key":"2310_CR20","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"key":"2310_CR21","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1373\/clinchem.2008.103556","volume":"54","author":"A Geistanger","year":"2008","unstructured":"Geistanger A, Arends S, Berding C et al (2008) Statistical methods for monitoring the relationship between the IFCC reference measurement procedure for hemoglobin A1c and the designated comparison methods in the United States, Japan, and Sweden. Clin Chem 54:1379\u20131385","journal-title":"Clin Chem"},{"key":"2310_CR22","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1373\/clinchem.2010.150250","volume":"57","author":"DM Nathan","year":"2011","unstructured":"Nathan DM, Steffes MW, Sun W, Rynders GP, Lachin JM (2011) Determining stability of stored samples retrospectively: the validation of glycated albumin. Clin Chem 57:286\u2013290","journal-title":"Clin Chem"},{"key":"2310_CR23","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0002-9149(01)02047-1","volume":"88","author":"EJ Schaefer","year":"2001","unstructured":"Schaefer EJ, Audelin MC, McNamara JR et al (2001) Comparison of fasting and postprandial plasma lipoproteins in subjects with and without coronary heart disease. Am J Cardiol 88:1129\u20131133","journal-title":"Am J Cardiol"},{"key":"2310_CR24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1507\/endocrj.K05-137","volume":"53","author":"M Koga","year":"2006","unstructured":"Koga M, Matsumoto S, Saito H, Kasayama S (2006) Body mass index negatively influences glycated albumin, but not glycated hemoglobin, in diabetic patients. Endocr J 53:387\u2013391","journal-title":"Endocr J"},{"key":"2310_CR25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.diabres.2009.03.014","volume":"84","author":"Y Tahara","year":"2009","unstructured":"Tahara Y (2009) Analysis of the method for conversion between levels of HbA1c and glycated albumin by linear regression analysis using a measurement error model. Diabetes Res Clin Pract 84:224\u2013229","journal-title":"Diabetes Res Clin Pract"},{"key":"2310_CR26","doi-asserted-by":"crossref","first-page":"960","DOI":"10.2337\/dc10-1945","volume":"34","author":"E Selvin","year":"2011","unstructured":"Selvin E, Francis LM, Ballantyne CM et al (2011) Nontraditional markers of glycemia: associations with microvascular conditions. Diabetes Care 34:960\u2013967","journal-title":"Diabetes Care"},{"key":"2310_CR27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.7326\/0003-4819-154-5-201103010-00004","volume":"154","author":"E Selvin","year":"2011","unstructured":"Selvin E, Steffes MW, Ballantyne CM, Hoogeveen RC, Coresh J, Brancati FL (2011) Racial differences in glycemic markers: a cross-sectional analysis of community-based data. Ann Intern Med 154:303\u2013309","journal-title":"Ann Intern Med"},{"key":"2310_CR28","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1159\/000287561","volume":"31","author":"BI Freedman","year":"2010","unstructured":"Freedman BI, Shihabi ZK, Andries L et al (2010) Relationship between assays of glycemia in diabetic subjects with advanced chronic kidney disease. Am J Nephrol 31:375\u2013379","journal-title":"Am J Nephrol"},{"key":"2310_CR29","first-page":"825","volume":"49","author":"M Tominaga","year":"2006","unstructured":"Tominaga M, Makino H, Yoshino G et al (2006) Report of the committee on standardization of laboratory testing related to diabetes mellitus of Japan Diabetes Society: determination of reference intervals of hemoglobin A1c (IFCC) and glycoalbumin in the Japanese population. J Japan Diab Soc 49:825\u2013833","journal-title":"J Japan Diab Soc"},{"key":"2310_CR30","first-page":"178","volume":"37","author":"I Takei","year":"2008","unstructured":"Committee on Diabetes Mellitus Indices, Japan Society of Clinical Chemistry, Takei I et al (2008) JSCC recommended method for glycated albumin measurement in serum. Jpn J Clin Chem 37:178\u2013191","journal-title":"Jpn J Clin Chem"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-011-2310-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-011-2310-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-011-2310-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T01:22:07Z","timestamp":1593048127000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-011-2310-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,27]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["2310"],"URL":"https:\/\/doi.org\/10.1007\/s00125-011-2310-6","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,27]]}}}